Mellen Center for MS Treatment and Research, Neurologic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Department of Neuroscience, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Ann Neurol. 2020 Jul;88(1):81-92. doi: 10.1002/ana.25743. Epub 2020 May 1.
Thalamic atrophy is among the earliest brain changes detected in patients with multiple sclerosis (MS) and the degree of thalamic atrophy is a strong predictor of disability progression. The causes of thalamic atrophy are not fully understood. Here, we investigate the contributions of thalamic demyelinated lesions, thalamic neuronal loss, and cerebral white matter (WM) lesions to thalamic volume.
We used postmortem in situ magnetic resonance imaging (MRI) scans of 95 subjects with MS to correlate thalamic lesion volumes with global MRI metrics. We histologically characterized thalamic demyelination patterns and compared neuronal loss and neuritic pathology in the thalami with the extremes of volume.
Grossly apparent thalamic discolorations in cm-thick brain slices were T2/fluid-attenuated inversion recovery (FLAIR) hyperintense, T1-hypointense, and appeared as perivascular demyelinated lesions with dystrophic neurons/axons. Subependymal demyelinated lesions with axonal loss and microglial/macrophage activation were also observed. The 12 subjects with the least thalamic volume had a 17.6% reduction of median neuronal density in the dorsomedial/ventrolateral and pulvinar nuclei compared with the 14 subjects with the greatest thalamic volume (p = 0.03). After correcting for age, disease duration, sex, and T2 lesion volume, the total (p = 0.20), ovoid (p = 0.31), or subependymal (p = 0.44) MRI thalamic lesion volumes correlated with thalamic volume. Thalamic volume correlated with cerebral T2 lesion volume (Spearman's rho = -0.65, p < 0.001; p < 0.0001 after correcting for age, disease duration, and sex).
Our findings suggest the degeneration of efferent/afferent thalamic projections and/or a neurodegenerative process as greater contributors to thalamic atrophy than thalamic demyelinating lesions. ANN NEUROL 2020 ANN NEUROL 2020;88:81-92.
丘脑萎缩是多发性硬化症(MS)患者最早检测到的脑改变之一,而丘脑萎缩的程度是残疾进展的强有力预测因子。丘脑萎缩的原因尚未完全阐明。在这里,我们研究了脱髓鞘的丘脑病变、丘脑神经元丢失以及脑白质(WM)病变对丘脑体积的贡献。
我们使用 95 例 MS 患者的死后原位磁共振成像(MRI)扫描,将丘脑病变体积与整体 MRI 指标相关联。我们对丘脑脱髓鞘模式进行了组织学特征描述,并比较了体积极值处的神经元丢失和神经丝病理学。
在 1 厘米厚的脑切片中,肉眼可见的丘脑变色在 T2/液体衰减反转恢复(FLAIR)上呈高信号,T1 上呈低信号,表现为血管周围脱髓鞘病变伴营养不良神经元/轴突。还观察到室管膜下脱髓鞘病变伴轴突丢失和小胶质细胞/巨噬细胞激活。12 例丘脑体积最小的患者,其背内侧/腹外侧和丘脑髓质核的神经元密度中位数降低了 17.6%,而 14 例丘脑体积最大的患者则降低了 17.6%(p = 0.03)。在校正年龄、疾病持续时间、性别和 T2 病变体积后,总(p = 0.20)、卵圆形(p = 0.31)或室管膜下(p = 0.44)MRI 丘脑病变体积与丘脑体积相关。丘脑体积与脑 T2 病变体积相关(Spearman's rho = -0.65,p < 0.001;校正年龄、疾病持续时间和性别后,p < 0.0001)。
我们的研究结果表明,传出/传入丘脑投射的变性和/或神经退行性过程是导致丘脑萎缩的更大因素,而不是脱髓鞘的丘脑病变。